Ektomun

N/A

Report date: 2026/03/19 16:58:34

Base Information

Drug NameEktomun
Drug Alias NameAnti-CD3/Anti-GD2 Trifunctional Bispecific T-Cell Engager (TRION/Lindis Biotech)antibody for melanoma(Trion)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsSmall Cell Lung CarcinomaMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrion Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrion PharmaTrion Research
Active IndicationsN/A
Inactive IndicationsSmall Cell Lung CarcinomaMelanoma

Other Information

ATC CodeN/A
Related LinksN/A